A hot topic also for radiopharmaceuticals and nuclear medicine patients: tremendous differences exist in patient access to innovative oncology treatments across European countries. A recent report presents the key delaying factors and strategies how to overcome them.
EANM goes fully virtual on October 22-30, 2020.
From the comfort of your desk SASAI – the Shared Audit and Supplier Assessment Initiative - helps you deliver the ABX advanced biochemical compounds GmbH (Germany) audit report directly to your regulatory authorities...
As part of a multi-disciplinary consortium, EANM was awarded with a 30-month project by the European Commission on the constant improvement of clinical audits, that started in January 2020.